EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TMEM106B C‐terminal fragments aggregate and drive neurodegenerative proteinopathy in transgenic Caenorhabditis elegans

Ruben Riordan, Aleen Saxton, Marina Han, Pamela J McMillan, Rebecca L Kow, Nicole F Liachko, Brian C Kraemer iD

Alzheimer's & Dementia · 2025-02 · 21 (2)

DOI: 10.1002/alz.14468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 23.12.2024. Verfasst von Ruben Riordan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Nerve Tissue Proteins, Membrane Proteins, Frontotemporal Lobar Degeneration, Neurodegenerative Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of Veterans Affairs, NIA NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Genetic variation in the lysosomal and transmembrane protein 106B (TMEM106B) modifies risk for several neurodegenerative disorders, especially frontotemporal lobar degeneration (FTLD). The C‐terminal (CT) domain of TMEM106B occurs as fibrillar protein deposits in the brains of dementia patients. METHODS To determine the TMEM CT aggregation propensity and neurodegenerative potential, we generated transgenic Caenorhabditis elegans expressing the human TMEM CT fragment aggregating in FTLD cases. RESULTS Pan‐neuronal expression of human TMEM CT in C. elegans causes severe neuronal dysfunction driving neurodegeneration. Cytosolic aggregation of TMEM CT proteins accompanied by behavioral dysfunction and neurodegeneration. Loss of pgrn‐1 did not modify TMEM CT phenotypes suggesting TMEM CT aggregation occurs downstream of PGRN loss of function. The mechanistic drivers of TMEM106B proteinopathy appear distinct from known modifiers of tauopathy. DISCUSSION Our data demonstrate that TMEM CT aggregation can kill neurons. TMEM106B transgenic C.elegans provide a useful model for characterizing TMEM106B proteinopathy‐mediated neurodegeneration in FTLD. Highlights Pan‐neuronal expression of human TMEM106B C‐terminal fragments (TMEM CT) in C. elegans neurons drives a suite of disease‐related phenotypes useful for modeling the molecular and cellular features of TMEM106B neuropathology. TMEM CT expression results in extensive TMEM aggregation and accumulation of highly detergent insoluble protein species. TMEM CT expression causes moderate to severe neuronal dysfunction dependent on TMEM CT abundance as measured by stereotypical behavioral readouts. TMEM CT expression drives significant neurodegenerative changes. Dendra2 tagged TMEM exhibits similar properties to untagged TMEM allowing ready visualization of the protein. TMEM CT aggregates accumulate adjacent to but not within lysosomes. PGRN loss of function does not impact TMEM CT toxicity. Modifiers of tau and TDP‐43 proteinopathies have little impact on TMEM CT‐related neurodegenerative phenotypes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nerve Tissue ProteinsMembrane ProteinsFrontotemporal Lobar DegenerationNeurodegenerative DiseasesAnimalsCaenorhabditis elegansAnimals, Genetically ModifiedHumansDisease Models, AnimalNeuronsCaenorhabditis elegans Proteins

Stichwörter der Autor:innen

TMEM106Bagingdementiafrontotemporal lobar degenerationneurodegenerationprogranulinproteinopathytau

Substanzen

TMEM106B protein, humanNerve Tissue ProteinsMembrane ProteinsCaenorhabditis elegans Proteins

Autor:innen und Institutionen

  • Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA.
  • Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Graduate Program in Neuroscience, University of Washington, Seattle, Washington, USA.
  • Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, USA.
  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Brian C Kraemer

Förderung

  • U.S. Department of Veterans Affairs
  • NIA NIH HHS
  • NIH HHS
  • NIDDK NIH HHS
  • NINDS NIH HHS
  • BLRD VA
  • Geriatric Research Education and Clinical Center
  • National Institutes of Health

Zitieren

APA

Riordan, R., Saxton, A., Han, M., McMillan, P. J., Kow, R. L., Liachko, N. F., & Kraemer, B. C. (2025). TMEM106B C‐terminal fragments aggregate and drive neurodegenerative proteinopathy in transgenic Caenorhabditis elegans. Alzheimer's & Dementia, 21(2). https://doi.org/10.1002/alz.14468

Vancouver

Riordan R, Saxton A, Han M, McMillan PJ, Kow RL, Liachko NF, et al. TMEM106B C‐terminal fragments aggregate and drive neurodegenerative proteinopathy in transgenic Caenorhabditis elegans. Alzheimer's & Dementia. 2025;21(2). doi:10.1002/alz.14468

BibTeX
@article{Riordan2025,
  author = {Riordan, Ruben and Saxton, Aleen and Han, Marina and McMillan, Pamela J and Kow, Rebecca L and Liachko, Nicole F and Kraemer, Brian C},
  title = {TMEM106B C‐terminal fragments aggregate and drive neurodegenerative proteinopathy in transgenic Caenorhabditis elegans},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {2},
  doi = {10.1002/alz.14468}
}
Kostenlos starten →